MED12L encodes a subunit of the mediator complex kinase module, which functions as a transcriptional coactivator essential for RNA polymerase II-mediated gene transcription 1. The protein is part of a four-subunit kinase module (along with MED13, CDK8/CDK19, and CCNC) that regulates transcriptional activity by modulating the mediator complex's interaction with RNA polymerase II 2. Functionally, MED12L acts through haploinsufficiency mechanisms - reduced gene dosage leads to moderate but significant alterations in RNA synthesis and transcriptional defects 1. Pathogenic variants in MED12L cause Nizon-Isidor syndrome, characterized by intellectual disability, developmental delay, speech impairment, autism spectrum disorder, corpus callosum abnormalities, and distinctive facial features 1. Recent evidence suggests MED12L may also contribute to mitotic instability, with one case showing diploid-triploid mosaicism 3. Beyond neurodevelopmental disorders, MED12L variants have been associated with susceptibility to guttate psoriasis in Chinese populations 4 and identified in genome-wide studies of infectious disease immune responses and irritable bowel syndrome 56. The gene exemplifies how mediator complex integrity is critical for proper neurological development and broader physiological functions.